Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Rapid and accurate point-of-care testing for SARS-CoV2 antibodies

Sally Esmail, Michael J. Knauer, Husam Abdoh, Benjamin Chin-Yee, Peter Stogios, Almagul Seitova, Ashley Hutchinson, Farhad Yusifov, Tatiana Skarina, Elena Evdokimova, Suzanne Ackloo, Lori Lowes, Courtney Voss, Benjamin D. Hedley, Vipin Bhayana, Ian Chin-Yee, Shawn S-C. Li
doi: https://doi.org/10.1101/2020.11.30.20241208
Sally Esmail
1Departments of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6G 2V4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Knauer
2Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Husam Abdoh
2Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Chin-Yee
3Divison of Hematology, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Stogios
5Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College St., Toronto, Ontario M5S 3E5, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Almagul Seitova
4Structural Genomics Consortium, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Hutchinson
4Structural Genomics Consortium, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farhad Yusifov
4Structural Genomics Consortium, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana Skarina
5Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College St., Toronto, Ontario M5S 3E5, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Evdokimova
5Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College St., Toronto, Ontario M5S 3E5, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Ackloo
4Structural Genomics Consortium, University of Toronto, 101 College St, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lori Lowes
2Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Courtney Voss
1Departments of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6G 2V4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin D. Hedley
2Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vipin Bhayana
2Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Chin-Yee
2Department of Pathology and Laboratory Medicine, Western University and London Health Sciences Centre, 800 Commissioners Rd E, London, Ontario N6A 5W9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shawn S-C. Li
1Departments of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6G 2V4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sli@uwo.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has grown into worst public health crisis since the 1918 influenza pandemic. As COVID-19 continues to spread around the world, there is urgent need for a rapid, yet accurate antibody test to identify infected individuals in populations to inform health decisions. We have developed a rapid, accurate and cost-effective serologic test based on antibody-dependent agglutination of antigen-coated latex particles, which uses ∼5 µl plasma and takes <5 min to complete with no instrument required. The simplicity of this test makes it ideal for point-of-care (POC) use at the community level. When validated using plasma samples that are positive or negative for SARS-CoV-2, the agglutination assay detected antibodies against the receptor-binding domain of the spike (S-RBD) or the nucleocapsid (N) protein of SARS-CoV-2 with 100% specificity and ∼98% sensitivity. Furthermore, we found that the strength of the S-RBD antibody response measured by the agglutination assay correlated with the efficiency of the plasma in blocking RBD binding to the angiotensin converting enzyme 2 (ACE2) in a surrogate neutralization assay, suggesting that the agglutination assay may be used to identify individuals with virus-neutralizing antibodies. Intriguingly, we found that >92% of patients had detectable antibodies on the day of positive viral RNA test, suggesting that seroconversion may occur earlier than previously thought and that the agglutination antibody test may complement RNA testing for POC diagnosis of SARS-CoV-2 infection.

Competing Interest Statement

SE, CV and SSCL are inventors in a provisional patent submitted by Western University

Funding Statement

This work was supported by a grant (to SSCL, ICY, MK, BCY and VB) from the Ontario Research Fund-COVID-19 Rapid Research Fund and by the Toronto COVID-19 Action Fund.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Blood samples were collected following a protocol (study number: 116284) approved by the Research Ethics Board (REB) of Western University. The plasma samples were de-identified prior to transfer from the Laboratory of Clinical Medicine (London Health Sciences Center, London, Canada) to a biosafety Level 3 (CL3) lab (ImPaKT, Western University) following Transportation of Dangerous Goods (TDG) guidelines. All plasma samples were heat-inactivated at 56 oC for 30 minutes at the ImPaKT CL3 facility as per Western university biosafety regulation. Heat inactivated plasma samples were then transferred to the testing laboratory.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data will be made available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 02, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Rapid and accurate point-of-care testing for SARS-CoV2 antibodies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rapid and accurate point-of-care testing for SARS-CoV2 antibodies
Sally Esmail, Michael J. Knauer, Husam Abdoh, Benjamin Chin-Yee, Peter Stogios, Almagul Seitova, Ashley Hutchinson, Farhad Yusifov, Tatiana Skarina, Elena Evdokimova, Suzanne Ackloo, Lori Lowes, Courtney Voss, Benjamin D. Hedley, Vipin Bhayana, Ian Chin-Yee, Shawn S-C. Li
medRxiv 2020.11.30.20241208; doi: https://doi.org/10.1101/2020.11.30.20241208
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Rapid and accurate point-of-care testing for SARS-CoV2 antibodies
Sally Esmail, Michael J. Knauer, Husam Abdoh, Benjamin Chin-Yee, Peter Stogios, Almagul Seitova, Ashley Hutchinson, Farhad Yusifov, Tatiana Skarina, Elena Evdokimova, Suzanne Ackloo, Lori Lowes, Courtney Voss, Benjamin D. Hedley, Vipin Bhayana, Ian Chin-Yee, Shawn S-C. Li
medRxiv 2020.11.30.20241208; doi: https://doi.org/10.1101/2020.11.30.20241208

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)